Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Gossamer Bio Inc GOSS

Healthcare Biotechnology
Gossamer Bio, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH). Its product candidate Seralutinib, also known as GB002, is an investigational inhaled, small molecule, platelet-derived growth factor receptor (PDGFR), colony-stimulating factor 1 receptor... see more

Recent & Breaking News (NDAQ:GOSS)

NOTICE For Investors In NASDAQ: GOSS: Lawsuit against Gossamer Bio, Inc. announced by Shareholders Foundation

Newsfile April 20, 2020

SHAREHOLDER ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Gossamer Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

ACCESSWIRE IA April 19, 2020

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gossamer Bio, Inc. - GOSS

ACCESSWIRE IA April 18, 2020

Gossamer Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing in Gossamer Bio, Inc. to Contact the Firm

Newsfile April 17, 2020

IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Gossamer Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

ACCESSWIRE IA April 17, 2020

Zhang Investor Law Announces Securities Class Action Lawsuit Against Gossamer Bio, Inc. - GOSS

GlobeNewswire April 17, 2020

UPCOMING DEADLINE: Block & Leviton Filed the First Lawsuit Against Gossamer Bio for Securities Fraud; Shareholders Who Have Lost Money Should Contact the Firm

GlobeNewswire April 16, 2020

IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Gossamer Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

ACCESSWIRE IA April 15, 2020

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Gossamer Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

ACCESSWIRE IA April 14, 2020

Gossamer Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Gossamer Bio, Inc. To Contact The Firm

Newsfile April 14, 2020

IMPORTANT SHAREHOLDER ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Gossamer Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

ACCESSWIRE IA April 13, 2020

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of TUFN, CRON and GOSS

ACCESSWIRE IA April 13, 2020

GOSS INVESTOR UPDATE: Bronstein, Gewirtz & Grossman, LLC Notifies Gossamer Bio, Inc. Shareholders of Class Action and Encourages Investors to Contact the Firm

Business Wire April 13, 2020

GOSS INVESTOR ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Gossamer Bio, Inc. Shareholders of Class Action and Encourages Investors to Contact the Firm

ACCESSWIRE IA April 13, 2020

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of ANAB, HAFC and GOSS

ACCESSWIRE IA April 12, 2020

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gossamer Bio, Inc. - GOSS

Canada NewsWire April 12, 2020

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of TVTY, CRON and GOSS

ACCESSWIRE IA April 8, 2020

IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Gossamer Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

ACCESSWIRE IA April 8, 2020

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of TUP, BDX and GOSS

ACCESSWIRE IA April 8, 2020

Shareholder Alert: Robbins LLP Announces It Is Investigating Gossamer Bio, Inc. (GOSS) on Behalf of Shareholders

Business Wire April 8, 2020